Hormonal Contraception is a type of birth control that uses hormones to prevent pregnancy.
This report contains market size and forecasts of Hormonal Contraception in global, including the following market information:
Global Hormonal Contraception Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Hormonal Contraception Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Hormonal Contraception companies in 2021 (%)
The global Hormonal Contraception market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
by Hormone Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Hormonal Contraception include Bayer AG, Merck & Co., Inc., Pfizer, Inc., Agile Therapeutics, Inc., Teva Pharmaceutical Industries Ltd., Amgen, Cipla Ltd., Glenmark Pharmaceuticals Inc. and Lupin Limited(Lupin Pharmaceuticals, Inc.), etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Hormonal Contraception manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Hormonal Contraception Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Hormonal Contraception Market Segment Percentages, by Type, 2021 (%)
by Hormone
Androgens
Estrogens
Progestrogens
Antiandrogens
Gonadotropins
by Method
Combined Oral
Oral Pill
Implanted
Injected
Intrauterine
Transdermal Patch
Global Hormonal Contraception Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Hormonal Contraception Market Segment Percentages, by Application, 2021 (%)
Hospital
Clinics
Gynaecology Centers
Others
Global Hormonal Contraception Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Hormonal Contraception Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Hormonal Contraception revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Hormonal Contraception revenues share in global market, 2021 (%)
Key companies Hormonal Contraception sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Hormonal Contraception sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Bayer AG
Merck & Co., Inc.
Pfizer, Inc.
Agile Therapeutics, Inc.
Teva Pharmaceutical Industries Ltd.
Amgen
Cipla Ltd.
Glenmark Pharmaceuticals Inc.
Lupin Limited(Lupin Pharmaceuticals, Inc.)
Novartis AG
Mylan N.V.
Johnson & Johnson
Ansell LTD
Mayer Laboratories, Inc.